NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically

NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically

Despite the great advances in medicine, mortality from cardiovascular diseases keeps on growing. This tendency is not likely to change considering the pandemic proportions of obesity and diabetes. Besides, the global population is more aged as life expectancy increases, and vascular aging plays a ke...

Bibliografiset tiedot
Päätekijät:	Ainara González-Moro, Inés Valencia, Licia Shamoon, Carlos Félix Sánchez-Ferrer, Concepción Peiró, Fernando de la Cuesta
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	MDPI AG 2022-01-01
Sarja:	Antioxidants
Aiheet:	NLRP3 inflammasome IL-1β IL-18 inflammaging pharmacology vascular
Linkit:	https://www.mdpi.com/2076-3921/11/2/269

Samankaltaisia teoksia

Research progress of NLRP3 inflammasome in the pathogenesis of psoriasis
Tekijä: Siman SHI, et al.
Julkaistu: (2022-10-01)

NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
Tekijä: Eleonora Mezzaroma, et al.
Julkaistu: (2021-02-01)

Role of the Nlrp3 Inflammasome in Microbial Infection
Tekijä: Paras K Anand, et al.
Julkaistu: (2011-02-01)

The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
Tekijä: Carol M. Artlett
Julkaistu: (2022-04-01)

Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
Tekijä: Anna Gritsenko, et al.
Julkaistu: (2020-09-01)

Acute Lung Injury and the NLRP3 Inflammasome
Tekijä: Gu W, et al.
Julkaistu: (2024-06-01)

The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome
Tekijä: Tara A. Gleeson, et al.
Julkaistu: (2024-07-01)

Pharmacological Inhibitors of the NLRP3 Inflammasome
Tekijä: Ayesha Zahid, et al.
Julkaistu: (2019-10-01)

Unraveling the role of NLRP3 inflammasome in allergic inflammation: implications for novel therapies
Tekijä: Hui-Fei Lu, et al.
Julkaistu: (2024-07-01)

The role of inflammasome in chronic viral hepatitis
Tekijä: Pin Wan, et al.
Julkaistu: (2024-05-01)

UVB-Induced Skin Autoinflammation Due to Nlrp1b Mutation and Its Inhibition by Anti-IL-1β Antibody
Tekijä: Yuya Murase, et al.
Julkaistu: (2022-06-01)

New insight into the role of the pathway NLRP1 and NLRP3 inflammasomes and IL-33 in ultraviolet-induced cutaneous carcinogenesis
Tekijä: Aleksandra Lesiak, et al.
Julkaistu: (2025-01-01)

INFLAMMASOME NLRP1 DISTINCTIVE FEATURES IN ATOPIC CONDITIONS
Tekijä: Денис Сергеевич Загрешенко, et al.
Julkaistu: (2023-08-01)

The Essential Role of NLRP3 Inflammasome in Atherosclerosis
Tekijä: Dewi Sukmawati
Julkaistu: (2023-06-01)

The important role of NLRP6 inflammasome in Pasteurella multocida infection
Tekijä: Xingping Wu, et al.
Julkaistu: (2022-10-01)

Juglone Suppresses LPS-induced Inflammatory Responses and NLRP3 Activation in Macrophages
Tekijä: Nam-Hun Kim, et al.
Julkaistu: (2020-07-01)

NLRP3 Inflammasome in Autoinflammatory Diseases and Periodontitis Advance in the Management
Tekijä: Babiker Rasha, et al.
Julkaistu: (2024-04-01)

The Role of Interleukin-17A and NLRP3 Inflammasome in the Pathogenesis of Graves’ Ophthalmopathy
Tekijä: Chih-Chung Lin, et al.
Julkaistu: (2023-04-01)

HuNoV Non-Structural Protein P22 Induces Maturation of IL-1β and IL-18 and N-GSDMD-Dependent Pyroptosis through Activating NLRP3 Inflammasome
Tekijä: Nini Chen, et al.
Julkaistu: (2023-05-01)

The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma
Tekijä: Victor S. M. C. Correa, et al.
Julkaistu: (2023-03-01)

NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis
Tekijä: Carlo Marchetti, et al.
Julkaistu: (2018-08-01)

Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
Tekijä: Nicola Potere, et al.
Julkaistu: (2022-11-01)

NLRP3 inflammasome in metabolic syndrome
Tekijä: Fang Wang, et al.
Julkaistu: (2021-04-01)

NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
Tekijä: Limin Song, et al.
Julkaistu: (2017-03-01)

Role of NLRP3 inflammasome in systemic sclerosis
Tekijä: Cong Lin, et al.
Julkaistu: (2022-08-01)

Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome
Tekijä: Fenqin Chen, et al.
Julkaistu: (2018-06-01)

An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
Tekijä: Aroa Baragaño Raneros, et al.
Julkaistu: (2021-11-01)

Activation and Pharmacological Regulation of Inflammasomes
Tekijä: Chen Chen, et al.
Julkaistu: (2022-07-01)

Cell-based <i>in vitro</i> hemoassay for evaluation of NLRP3-inflammasome activity
Tekijä: N. K. Ossina, et al.
Julkaistu: (2024-09-01)

High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis
Tekijä: Geraldine De Luca, et al.
Julkaistu: (2023-11-01)

Crocin attenuates the lipopolysaccharide-induced neuroinflammation via expression of AIM2 and NLRP1 inflammasome in an experimental model of Parkinson's disease
Tekijä: Solmaz Alizadehmoghaddam, et al.
Julkaistu: (2024-02-01)

Gene Expression of NLRP3 Inflammasome in Celiac Disease of Iraqi Children
Tekijä: Anwar I. S. Al-Assaf, et al.
Julkaistu: (2021-06-01)

The ASC Speck and NLRP3 Inflammasome Function Are Spatially and Temporally Distinct
Tekijä: Abhinit Nagar, et al.
Julkaistu: (2021-10-01)

The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: An optical coherence tomography study
Tekijä: Chao Xue, et al.
Julkaistu: (2022-10-01)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
Tekijä: Yao Shen, et al.
Julkaistu: (2022-08-01)

A study on the level of NLRP3 inflammasome in patients with premature rupture of membranes
Tekijä: Fen Xue, et al.
Julkaistu: (2023-09-01)

NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors
Tekijä: Yi Xu, et al.
Julkaistu: (2023-11-01)

NLRP3, NLRP12, and IFI16 Inflammasomes Induction and Caspase-1 Activation Triggered by Virulent HSV-1 Strains Are Associated With Severe Corneal Inflammatory Herpetic Disease
Tekijä: Pierre-Gregoire Coulon, et al.
Julkaistu: (2019-07-01)

Autophagy Inhibition Contributes to ROS-Producing NLRP3-Dependent Inflammasome Activation and Cytokine Secretion in High Glucose-Induced Macrophages
Tekijä: Jiezhi Dai, et al.
Julkaistu: (2017-08-01)

Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome
Tekijä: Rosalie Matico, et al.
Julkaistu: (2024-12-01)